Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk.

Autor: Kanis JA; Mary McKillop Institute for Health Research, Catholic University, AustralianMelbourne, Australia. w.j.pontefract@shef.ac.uk.; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK. w.j.pontefract@shef.ac.uk., Harvey NC; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK., Lorentzon M; Mary McKillop Institute for Health Research, Catholic University, AustralianMelbourne, Australia.; Sahlgrenska Osteoporosis Centre, Institute of Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Liu E; Mary McKillop Institute for Health Research, Catholic University, AustralianMelbourne, Australia., Schini M; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK., Abrahamsen B; Odense Patient Data Explorative Network, Institute of Clinical Research, University of Southern Denmark, Odense, Denmark., Adachi JD; Department of Medicine, McMaster University, Hamilton, Canada., Alokail M; Biochemistry Department, College of Science, Riyadh, Kingdom of Saudi Arabia., Borgstrom F; Quantify Research, Stockholm, Sweden., Bruyère O; Research Unit in Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium., Carey JJ; School of Medicine, University of Galway, Galway, Ireland., Clark P; Clinical Epidemiology Research Unit, Hospital Infantil de Mexico 'Federico Gomez', Mexico City, Mexico.; Faculty of Medicine of National Autonomous University of Mexico (Universidad, Nacional Autónoma de México), Mexico City, Mexico., Cooper C; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, UK., Curtis EM; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK., Dennison EM; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.; Victoria University of Wellington, Wellington, New Zealand., Díaz-Curiel M; Metabolic Bone Diseases Unit, Department of Internal Medicine, Hospital Universitario Fundación Jiménez Díaz, Universidad Autónoma Madrid, Madrid, Spain., Dimai HP; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Styria, Austria., Grigorie D; Carol Davila University of Medicine, Bucharest, Romania.; Department of Endocrinology & Bone Metabolism, National Institute of Endocrinology, Bucharest, Romania., Hiligsmann M; Department of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands., Khashayar P; International Institute for Biosensing, University of Minnesota, Minneapolis, USA., Lems W; Department of Rheumatology, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, USA., Lorenc RS; Multidisciplinary Osteoporosis Forum, Warsaw, Poland, Poland., Papaioannou A; McMaster University, Hamilton, ON, Canada., Reginster JY; Protein Research Chair, Biochemistry Dept, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia., Rizzoli R; Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland., Shiroma E; Laboratory of Epidemiology and Population Sciences, National Institute On Aging, Baltimore, MD, USA., Silverman SL; Department of Medicine, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Simonsick E; Translational Gerontology Branch, National Institute On Aging Intramural Research Program, Baltimore, MD, USA., Sosa-Henríquez M; University of Las Palmas de Gran Canaria, Grand Canaries, Spain., Szulc P; INSERM UMR 1033, University of Lyon, Hospital Edouard Herriot, Lyon, France., Ward KA; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK.; MRC Unit The Gambia, London School of Hygiene and Tropical Medicine, Banjul, The Gambia., Yoshimura N; Department of Preventive Medicine for Locomotive Organ Disorders, The University of Tokyo Hospital, Tokyo, Japan., Johansson H; Mary McKillop Institute for Health Research, Catholic University, AustralianMelbourne, Australia.; Sahlgrenska Osteoporosis Centre, Institute of Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Vandenput L; Mary McKillop Institute for Health Research, Catholic University, AustralianMelbourne, Australia., McCloskey EV; Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, UK.; Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.; Mellanby Centre for Musculoskeletal Research, MRC Versus Arthritis Centre for Integrated Research in Musculoskeletal Ageing, University of Sheffield, Sheffield, UK.
Jazyk: angličtina
Zdroj: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA [Osteoporos Int] 2024 Sep; Vol. 35 (9), pp. 1487-1496. Date of Electronic Publication: 2024 Jul 03.
DOI: 10.1007/s00198-024-07162-w
Abstrakt: Task Force on 'Clinical Algorithms for Fracture Risk' commissioned by the American Society for Bone and Mineral Research (ASBMR) Professional Practice Committee has recommended that FRAX® models in the US do not include adjustment for race and ethnicity. This position paper finds that an agnostic model would unfairly discriminate against the Black, Asian and Hispanic communities and recommends the retention of ethnic and race-specific FRAX models for the US, preferably with updated data on fracture and death hazards. In contrast, the use of intervention thresholds based on a fixed bone mineral density unfairly discriminates against the Black, Asian and Hispanic communities in the US. This position of the Working Group on Epidemiology and Quality of Life of the International Osteoporosis Foundation (IOF) is endorsed both by the IOF and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
(© 2024. International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation.)
Databáze: MEDLINE
Externí odkaz: